functional relevance of these modifications are largely unclear. Nonetheless, mitochondria 21 possess multiple resident phosphatases, suggesting that protein dephosphorylation may be 22 broadly important for mitochondrial activities. To explore this, we deleted the poorly characterized 23 matrix phosphatase Pptc7 from mice using CRISPR-Cas9 technology. Strikingly, Pptc7 -/mice 24 exhibited marked hypoketotic hypoglycemia, elevated acylcarnitines, and lactic acidosis, and died 25 soon after birth. Pptc7 -/tissues had significantly diminished mitochondrial size and protein content 26 despite normal transcript levels, but consistently elevated phosphorylation on select mitochondrial 27 proteins. These putative Pptc7 substrates include the protein translocase complex subunit 28 Timm50, whose phosphorylation reduced import activity. We further find that phosphorylation in 29 or near the mitochondrial targeting sequences of multiple proteins can disrupt their import rates 30 and matrix processing. Overall, our data define Pptc7 as a protein phosphatase essential for 31 proper mitochondrial function and biogenesis during the extrauterine transition.
SUMMARY
The full penetrance of perinatal lethality in the Pptc7 knockout pups led us to investigate matched glucose and ketone levels across mice demonstrates hypoketotic hypoglycemia (Figure function likely influences multiple metabolic pathways, and that its expression is required for the use of multiple nutrients in the perinatal stage. were decreased only in KO heart and liver tissues ( Figure S3C, S3D) . Notably, Bnip3a stress-146 activated protein involved in mitophagy 34 is elevated in KO tissue, suggesting that mitophagy 147 might play a role in these decreased protein levels. Importantly, nuclear-encoded mitochondrial 148 mRNA transcripts were not decreased (other than the CRISPR-targeted Pptc7) ( Figure 3E ), 149 suggesting that disruption of mitochondrial protein homeostasis in Pptc7-null tissues occurs post-150 transcriptionally.
151
To further examine how this loss of mitochondrial proteins is manifest at the cellular level, 152 we performed electron microscopy of tissue slices from P0 mice. In both heart ( Figure 3F , G) and 153 liver ( Figure 3I , J) mitochondria from KO mice were significantly smaller than those from WT mice.
154
On average, mitochondria from KO mice had ~40% ( Figure 3H ) and ~34% ( Figure 3K ) of the 155 surface area of WT mice in heart and liver, respectively. As such, certain mitochondrial defects 156 that we observe in KO tissues, such as decreased citrate synthase activity ( Figure S3E , F) and
We next sought to identify candidate Pptc7 substrates from our analyses above whose dysregulation could give rise to the marked mitochondrial dysregulation we observe in the KO 189 mice. Timm50 is among the most significantly elevated phosphoproteins in Pptc7 KO tissues, and 190 its identification in both PTC7 knockout yeast 17 and our previous study of obese mice 6 (Table 1) 191 suggests that this phosphorylation may have functional relevance under multiple conditions. The 192 phosphorylation site on Timm50 (Tim50p in yeast) occurs on the matrix-facing N-terminal tail in 193 both the yeast and mouse orthologs ( Figure 5A ). Although Timm50 is essential in both S.
194
cerevisiae 35 and M. musculus 36 , we hypothesized that a less severe disruption of 195 Tim50p/Timm50-mediated protein import activity could generate many of the pleiotropic effects 196 seen in ∆ptc7 yeast and Pptc7 KO mice. Indeed, a recent study identified compound 197 heterozygous mutations in TIMM50 in a patient with a mitochondrial disorder whose tissues 198 exhibited a similar decrease in respiratory chain components as our Pptc7 KO mice 37 .
199
To test whether Tim50p phosphorylation affects mitochondrial protein import, we 200 generated a strain of yeast expressing WT Tim50p, or a non-phosphorylatable (S104A) or 201 phosphomimetic (S104E) FLAG-tagged mutant ( Figure 5B ). As TIM50 is essential, we used a 202 previously characterized strain expressing the endogenous TIM50 gene under a galactose-203 inducible promoter (GAL7) 38 , which reduces growth on non-fermentable carbon sources in the 204 absence of galactose ( Figure S5A ). This phenotype could be rescued fully by exogenous 205 expression of Tim50p ( Figure S5A ) and Tim50p S104A ( Figure S5A ), while expression of the 206 phosphomimetic mutant Tim50p S104E exhibited a slight growth defect ( Figure S5B ). To test 207 whether Tim50p phosphorylation affects import efficiency, we performed import assays using 208 recombinant cytochrome b2-(167)∆19-DHFR-a well-established, matrix-targeted model 209 substrate 39 -into mitochondria isolated from strains expressing WT Tim50p or a non-210 phosphorylatable S104A or phosphomimetic S104E mutant. Mitochondria expressing Tim50p 211 with mutant S104 had import defects, with Tim50p S104E mitochondria importing cytochrome b2-(167)∆19-DHFR almost three-fold less efficiently than WT ( Figure 5C , quantified in D). These data suggest that phosphorylation at this site can inhibit mitochondrial protein import.
214
Given the elevation of Tim50p S104 phosphorylation in ptc7 yeast 17 , we next tested broadly influence metabolic pathways, and may contribute to the widespread defects seen in the to mitochondrial protein import. We noticed that amongst elevated (p<0.05) mitochondrial 243 phosphoisoforms identified in mouse and yeast, 11 candidate Pptc7/Ptc7p substrates have 244 phosphorylated residues that lie within or directly proximal to their mitochondrial targeting 245 sequences ( Figure 6A ). The localization of these phosphorylation events, coupled with data 246 suggesting that Ptc7p/Pptc7 modulates mitochondrial protein import ( Figure 5 ), suggest that the 247 phosphatase may play an addition role in import through the dephosphorylation of these 248 "phospho-MTS" substrates.
249
One such phospho-MTS substrate, Hadh, can metabolize multiple nutrients that are 250 disrupted in Pptc7 KO mice (e.g. BCAAs, lysine, fatty acids) 46 ( Figure 6B ), and thus its dysfunction 251 could contributes to the KO metabolic phenotypes. Hadh phosphorylation is also elevated in both 252 tissues, and ranks third in fold change and q-value amongst > 9000 phosphoisoforms identified 253 in liver ( Figure 4E , Table 1 ). To test whether PPTC7 can directly dephosphorylate phospho-MTS 254 substrates, we generated recombinant human HADH with site-specific phosphoserine 255 incorporation at S13 47, 48 (see Methods for details). We validated phosphoserine incorporation 256 using PhosTag gels, which showed a mobility shift for phosphorylated, but not WT, HADH (Figure
257
6C, lanes 1 and 2). Further, WT PPTC7, but not an inactive mutant, was able to dephosphorylate 258 HADH ( Figure 6C ). These results were recapitulated with a second phospho-MTS substrate, 259 ETHE1 ( Figure S6A ), demonstrating PPTC7 can directly dephosphorylate phospho-MTS 260 substrates in vitro.
261
We next tested whether HADH S13 phosphorylation affects enzyme activity, but found no to the mitochondrial targeting sequence of Hadh may instead affect protein import or processing. expressed phosphomimetic (S13E) and non-phosphorylatable (S13A) HADH in 293 cells and 268 found that the S13E mutant was not properly processed ( Figure 6D ). We observed similar protein 269 processing and/or stability errors with phosphomimetic mutation of other phospho-MTS 270 substrates, including ETHE1 ( Figure S6D ), Naxe ( Figure S6E ), and Iscu ( Figure S6F ). To 271 determine whether the MTS-proximal phosphomimetic mutation is sufficient to disrupt processing,
272
we generated chimeras containing the N-terminus of HADH fused to GFP and found that the 273 S13E mutation likewise disrupted processing of the fusion protein ( Figure 6E , S6G). Importantly, 274 S13E-HADH-GFP still localized to mitochondria ( Figures 6F, S6H ), suggesting that the 275 processing defect is not due to altered cellular targeting.
276
We next aimed to measure in vitro mitochondrial import efficiency on phospho-MTS 277 substrates. Our in vitro site-specific phospho-incorporation system noted above could not be 278 imported-an established problem for proteins produced in cell-free and E. coli-based systems 49-279 51 . Instead, we performed import assays with recombinant radiolabeled WT, S13A, and S13E 280 HADH. Each construct could be imported into mitochondria, as evidenced by the time-dependent 281 accumulation of proteinase K-protected species ( Figure 6G ); however, HADH S13E imported 282 more slowly relative to WT and S13A HADH proteins. Additionally, phosphomimetic mutation of 283 S13 HADH disrupted processing, as only full-length protein accumulated in mitochondria ( Figure   284 6G). To confirm the processing defect, we subjected HADH, S13A, and S13E mutants to an in 285 vitro MPP processing assay that is uncoupled from protein import 52 . MPP (mitochondrial 286 processing peptidase) removes MTS sequences upon entry into the matrix, and this processing 287 event is critical for mature protein stability 53 . We find that phosphomimetic mutation of S13 mutants were processed normally. With the caveat that we are analyzing phosphomimetic 290 mutants, these data suggest that phosphorylation of HADH proximal to its MTS is sufficient to 291 dampen, but not eliminate, mitochondrial import, and that dephosphorylation of HADH after 292 translocation is required for MPP processing and mature protein stability. As failure to remove 293 mitochondrial targeting sequences is associated with disrupted protein stability, these data 294 suggest that an inability to dephosphorylate and subsequently process these proteins may further 295 contribute to the decreased mitochondrial content and metabolic defects seen in Pptc7 KO mice. 303 Surprisingly, we find that Pptc7 is an essential gene in mammalian development, with its knockout 304 leading to fully penetrant perinatal lethality.
305
Perinatal lethality in mouse models is often associated with defects in metabolism, when 306 the newborn pup experiences a robust metabolic transition from placental to extrauterine 307 nutrients 23 . Pptc7 KO pups present with hypoketotic hypoglycemia-typically associated with FAO 308 disorders 29 -which is the likely cause of their death. Despite this presentation, our molecular 309 characterization using metabolomics, proteomics, and electron microscopy suggests a broader 310 mitochondrial dysfunction, which, in certain circumstances, is also associated with hypoketotic 311 hypoglycemia 31 . For example, knockout of Cluh, an RNA-binding protein that selectively 312 influences mitochondrial biogenesis, causes perinatal lethality in mice with metabolic defects (e.g.
313
hypoglycemia and hyperprolinemia) coupled with a stark decrease in the mitochondrial homeostasis (e.g. Cluh and Pptc7) can cause symptoms similar to classes of inborn errors of metabolism through broad mitochondrial dysfunction.
317
The global metabolic and mitochondrial defects seen in Pptc7 KO mice are likely due to 318 aberrantly elevated phosphorylation of mitochondrial proteins. We focused our attention on two 319 subsets of these phosphoproteins that could influence mitochondrial protein import and thus have 320 widespread effects within this organelle. While both subsets affect mitochondrial protein import,
321
we propose that elevated phosphorylation on Timm50 and Hadh mediate mitochondrial 322 dysfunction through two distinct mechanisms: via direct dampening of the import machinery 323 (Timm50), and by decreasing the import rate and/or processing of select mitochondrial-targeted 324 precursor proteins (e.g. Hadh). The mitochondrial import machinery is regulated by kinases in 325 yeast [55] [56] [57] [58] , and phosphorylation of TOM complex proteins is plausible given their accessibility to 
332
One possible mechanism for matrix-localized protein phosphorylation is that the 333 modification of select mitochondrial proteins occurs outside of the mitochondrion. Our data 334 support a model in which phosphorylation outside of mitochondria influences Hadh import rate 335 and downstream protease processing. In plants, phosphorylation of the targeting sequences of 336 chloroplast-bound proteins can alter their import efficiency by promoting or disrupting molecular 337 associations with the import complex itself, or with chaperones that facilitate import 62, 63 .
338
Consistently, phosphorylation of mitochondrial precursors such as GSTA4-4 64 , CYP2B1, and 339 CYP2E1 65 increases their association with cytosolic chaperones (e.g. Hsp70) to promote import, complex 55 . Alternatively, precursor phosphorylation on mitochondrial proteins including CNP2 66 and Tom40p 56 decrease or inhibit targeting to the organelle, consistent with our data on Hadh proteins 63 , but a candidate phosphatase has not yet been identified. Plants have multiple Pptc7 paralogs 76 , with a subset predicted to be chloroplast-localized, suggesting that Pptc7 paralogs 369 likewise may mediate these functions in plants. It is also notable that Timm50 has a vestigial 370 phosphatase domain 77 , which perhaps once functioned to dephosphorylate these proteins before 371 matrix import. In most organisms, Timm50 does not possess critical catalytic residues within its 372 phosphatase domain 77 ; however, in select lower organisms, such as the parasitic T. Brucei, 373 Timm50 (called TbTim50) retains phosphatase activity 78 . In this species, ablation of catalytic 374 phosphatase residues alters the stability of mitochondrial proteins such as VDAC 78 , suggesting 375 functional relevance. It is tempting to speculate that Timm50, and ultimately Pptc7, have evolved 376 to coordinate dephosphorylation of proteins targeted to the mitochondrion.
377
Overall, our data add to a growing narrative that mitochondrial PTMs are widespread and 378 impactful. It remains largely unclear whether the bulk of these PTMs are regulatory in nature, or 379 are instead adventitious and unintentionally disruptive, and thus merely need to be removed to 380 maintain optimal mitochondrial function. It is intriguing that our work on phosphorylation draws 381 parallels to mitochondrial acylation, where the enzymes tasked with removing PTMs are better 382 understood and seem to bear the larger metabolic managerial burden. In this regard, it is further 383 noteworthy that mice lacking the mitochondrial deacetylase Sirt3 exhibit similar phenotypes to the 384 Pptc7 KO mice, albeit to a lesser extent and not until they are stressed 79, 80 . However, our data 385 also suggest that some mitochondrial phosphorylation events have important regulatory potential.
386
First, the fact Pptc7 KO mice seemingly develop normally, but fail to thrive during a specific stage, 387 is perhaps consistent with a regulatory switch of sorts. Second, our data lead us to speculate that 388 select mitochondrial proteins are phosphorylated in the cytosol, and then dephosphorylated by 389 phosphatases within the organelle. In this model, proteins would be available to various cytosolic 390 kinases, whose classic signaling functions may then serve to direct proteins to mitochondria or to 391 alter their import rates. Regardless of its regulatory potential, our data demonstrate that Pptc7 is 392 required for surviving the perinatal transition, and show that protein dephosphorylation within the mitochondrial matrix is essential for mammalian development. Further studies will be required to understand the full repertoire of Pptc7 substrates, the potential regulation of this phosphatase, 395 and the physiological consequences of Pptc7 disruption in conditions beyond birth.
METHODS

Creation of the Pptc7 knockout mouse model
A Pptc7 knockout strain was generated using CRISPR-Cas9 technology in the C57BL/6J (B6) strain of Mus musculus [NCBItax:10090]. Mutational details are provided at MGI; Pptc7 em1Pag at MGI:6094244, and Pptc7 em2Pag at MGI:6143811. The second and third coding exons of Pptc7 were targeted for genome editing using two target sequences to maximize specificity (all predicted off-target sites had (i) at least 3 mismatches, with at least 1 mismatch in the 12bp seed region or (ii) 2 mismatches in the seed region). In vitro transcription template was generated by overlap-extension PCR with one oligo carrying a 5' T7 adapter, the target sequence, and a portion of the common gRNA sequence, and the other oligo carrying the antisense common gRNA sequence. In vitro template was column-purified and in vitro transcribed with the MEGAshortscript kit (Thermo-Fisher), and the resultant gRNA was cleaned with the MEGAclear kit (Thermo-Fisher). For injection-grade purification, gRNA was ammonium acetate purified, washed with 70% ethanol, and resuspended in injection buffer. One-cell fertilized C57BL/6J embryos derived from mice obtained from Jackson laboratories were microinjected with a mixture of both gRNAs (25 ng/ul each) and Cas9 protein (PNA Bio, 40 ng/ul), and then implanted into pseudopregnant B6 recipients. Tail DNA was harvested from resultant pups at weaning and used for genotyping.
Breeding, care, and selection of mice for experimental procedures
All animal work was done in accordance with IACUC approval (protocol/animal welfare assurance #A3368-01). The Pptc7 -/-Mus musculus strain was generated via CRISPR and is registered with MGI under the names C57BL/6J-Pptc7 em1Pag (accession number MGI:6094249) and C57BL/6J-Pptc7 em2Pag (accession number MGI:6143812); two strains are registered as two independently segregating Pptc7 -/alleles were generated in our founder mouseone with a 4 bp deletion in exon 2 (hereby called E2; MGI:6094244), and one with a 1 bp deletion in exon 3 (hereby called E3; MGI:6143811). As the phenotypes of all Pptc7-null genotypes were identical (see Figure S1 ), all genotypes are collectively annotated as "Pptc7 -/mice" and not by their specific alleles unless noted in the text or figure legends. The C57BL/6J wild type strain (Jackson Laboratories) was used for the generation of the Pptc7-CRISPR strain as well as for outbreeding. Mice were housed in a pathogen-free vivarium on a 12-hr light:dark cycle. Mice were group housed by strain and sex under temperature-and humidity-controlled conditions and received ad libitum access to water and food. Upon weaning, mice were maintained on a standard chow diet (Formulab 5008; 17.0% kcal fat; 56.5% carbohydrate; 26.5% protein) Strains were housed within the same vivarium throughout the duration of the study. Studies were performed with P0 mouse pups, sacrificed within 24 hours of their birth unless otherwise noted. Sex was not determined for experiments as males and females are indistinguishable at P0. Littermates were typically selected according to genotype and randomly assigned to experimental groups.
Genotyping analysis
Tail tips were isolated from each mouse and used as a source of genomic DNA (gDNA).
Tails were resuspended in 600 µl of Genomic Lysis Solution (20 mM Tris, pH 8.0, 150 mM NaCl, 100 mM EDTA, 1% SDS) supplemented with 3 µl concentrated proteinase K (Roche) and incubated at 55ºC overnight. After the overnight incubation, samples were cooled to room temperature for 10 min. before the addition of 200 µl Protein Precipitation Solution (Qiagen). Samples were then incubated on ice for 5 min. before vortexing for ~15 s. per sample. Samples were centrifuged (16K x g) for 5 min. to pellet precipitated proteins. The supernatant was removed and DNA was purified via isopropanol precipitation. gDNA was quantified using a Nanodrop (Thermo-Fisher) and ~300 ng of gDNA was added to each genotyping reaction. We generated a genotyping strategy that exploited unique restriction sites that were either created (E3d1) or 
Next generation sequencing
The F0 founder mouse was sacrificed at 18 months of age via CO2 asphyxiation and tissues isolated, including brain (cerebrum), small intestine, kidney, skeletal muscle (gastrocnemius), spleen, stomach, liver, and heart, and tissues from two heterozygous 
Serum metabolite measurements
After decapitation of P0 pups, a small amount of whole blood was used to measure blood glucose using a CVS Health Advanced Blood Glucose Meter (CVS). Blood glucose levels were taken at least twice, and averaged values reported for each mouse.
The remainder of the blood was collected, spun at 16.1K x g for 10 min. at room temperature, serum isolated and stored at -80ºC until use. Circulating insulin was assayed using the Ultra Sensitive Mouse Insulin ELISA kit (Crystal Chem) according to manufactuer's instructions using the "Low Range Assay" protocol. Briefly, serum from n=8 WT, n=5 heterozygous, and n=10 KO mice was thawed on ice. 5 l of serum was assayed for each mouse and quantified relative to the standard curve generated from the kit. Lactate levels were measured in serum isolated from n=9 WT, n=20 heterozygous, and n=7 KO mice mice using the Lactate Colorimetric/Fluorometric Assay Kit (BioVision) according to manufacturer's instructions, using 5 l of serum from each mouse quantified relative to the standard curve generated from the kit. Ketones were measured in serum isolated from newborn mice using the Ketone Bodies Kit (both R1 and R2 sets, Wako Biosciences) as previously described 6 . Serum from n=9 WT, n=13 heterozygous, and n=6 KO mice was thawed on ice, and 5 l was assayed for each mouse and quantified relative to a -hydroxybutyrate standard curve. For all serum tests, values reported are averaged from all measurements per group, and significance was tested using a two-tailed Student's t-test.
Metabolomics
Heart and liver tissues were immediately harvested and snap frozen in liquid nitrogen unless otherwise noted. Metabolites were extracted from cryo-pulverized tissue with a solvent mixture consisting of 7:2:1 HPLC grade methanol:water:chloroform; this was and CoQ intermediates were quantified from peak area using Thermo's Tracefinder application. GC features were quantified using in-house software (modified from 82 ), and lipid features were quantified using the Thermo's Compound DiscovererTM 2 application. Identification of features was performed with spectra matching to library of standards (NIST 14 83 ) or predicted fragmentation spectra (LipiDex, 84 ).
Electron microscopy
Tissues were harvested from litters of live P0 pups and were quickly washed in PBS and fixed in ~5 ml of fixation buffer (2.5% glutaraldehyde, 2.0% paraformaldehyde in 0.1M sodium phosphate buffer, pH 7.4) overnight @ 4°C. The tissue was then post fixed in 1% Osmium Tetroxide in the same buffer for 3 hrs @ RT, and the samples were dehydrated in a graded ethanol series, then further dehydrated in propylene oxide and embedded in Epon epoxy resin. Semi-thin (1 µm) sections were cut with a Leica EM UC6 Ultramicrotome and collected on 200 mesh copper grids. Sections were and contrasted with Reynolds lead citrate and 8% uranyl acetate in 50% EtOH. Ultrathin sections were observed with a Philips CM120 electron microscope and images were captured with an AMT BioSprint side mounted digital camera using AMT Capture Engine software.
Enzyme assays
Citrate synthase activity was assayed as previously described 17 using genotype verified tissues (n=3-4 each genotype, wild type and Pptc7 knockout heart and tissues). Error was calculated using standard deviation, and significance was calculated using a Student's t test. Hadh activity was assayed as previously described 85 . Briefly, recombinant human HADH (Entrez Gene #3033) or HADH site-specifically phosphorylated at S13 (see "Phosphoserine incorporation of recombinant proteins using cell free protein synthesis" for more details) were generated with a C-terminal FLAG tag using cell free protein synthesis. Proteins were immunoprecipitated (IPed) using M2-FLAG antibody-conjugated magnetic beads, eluted in FLAG peptide, and HADH activity was assayed using 2.5 l eluate from each IP (corresponding to ~200 ng recombinant protein per reaction). Error was calculated using standard deviation, and significance was calculated using a Student's t test.
Quantitative multiplexed proteomics and phosphoproteomics
Protein from lysed, homogenized mouse tissues was digested into tryptic peptides following previously reported protocols. 86 This yielded sufficient material to label 0.35 mg of each heart sample and 0.5 mg of each liver sample with tandem mass tags (TMT10plex Isobaric Label Reagent Set, Thermo-Fisher). Labeling was performed following manufacturer recommended protocols except for the peptide:label ratio, which was changed to 0.5:0.8::mg:mg. Equal amounts of sample were combined for each 10plex experiment following validation of labelling efficiency (> 95% labelling of N-terminal amines). Phosphopeptide enrichment with titanium chelation (Ti-IMAC, ReSyn Biosciences) was performed on pooled samples using previously reported methods 87 .
The depleted sample was saved for protein quantitation. 500 µg of each depleted sample and the entirety of each phosphopeptide enrichment were separated over an Acquity BEH C18 reverse phase column (130 Å pore size, 1. 
RNA isolation and qPCR
RNA was isolated using an RNeasy kit (Qiagen) per manufacturer's instructions. cDNA was prepared using 500 ng of total RNA using the SuperScript III First-Strand Synthesis System (Thermo-Fisher). cDNA was made exclusively with the oligo(dT) primer, and the kit was used according to the manufacturer's protocol. cDNA was normalized, and 100 ng was used as a template for each qPCR reaction. Reactions were set up using 1x
PowerSYBR master mix (Thermo-Fisher), 200 nM forward and reverse primers (each) and water to a final volume of 20 l total. qPCR was run on a QuantStudio 6 Flex (Applied Biosystems) and data were captured using QuantStudio Real Time PCR system software. Data were analyzed using the Ct method (n=3-4 samples per genotype), with error bars representing standard deviation and significance calculated using a two-tailed Student's t test.
Cloning and site directed mutagenesis
Escherichia coli strain DH5α (NEB) was used for all cloning applications and grown at 37 °C in LB media with antibiotics. Escherichia coli strain BL21-CodonPlus (DE3)-RIPL (Agilent) was used for all protein expression and purification purposes. Site directed mutagenesis was performed as previously described 81 .
Mitochondrial import assays
Various strains derived from the haploid W303 (his3 leu2 lys2 met15 trp1 ura3 ade2) yeast were used for mitochondrial isolation for import assays. The ptc7 strain was generated in W303 yeast as previously described 17 . The Tim50p studies were performed with a previously described W303 strain in which the TIM50 ORF was placed under control of the GAL7 promoter 38 . For mitochondrial isolation from yeast, a single colony of W303 yeast was incubated in 3-4 ml of YPD media overnight. 1 x 10 8 cells were diluted into 500 ml of YEP supplemented with 3% glycerol 0.1% dextrose. Yeast were grown at 30°C in an orbital shaker (230 rpm) for 19-20 hrs to a final OD of ~5-6 (with an OD of 1 = 1e7 cells). Mitochondria were isolated as previously described for mitochondrial import 91 . Isolated mitochondria were resuspended using wide-bore tips to a final concentration of 10 mg/ml in SEM buffer (250 mM sucrose, 1 mM EDTA, and 10 mM MOPS, pH 7.2), snap frozen in liquid nitrogen, and stored at -80°C until use in import assays.
Recombinant HADH or cytochrome b2-(167)∆19-DHFR (a gift from Elizabeth Craig) were generated using the quick TnT® Quick Coupled Transcription/Translation System (Promega) using either the T7 kit (HADH) or the SP6 kit (cytochrome b2-(167)∆19-DHFR) supplemented with 35 S-Methionine and Cysteine (EasyTag EXPRESS35S protein labeling mix, Perkin Elmer) according to the manufacturer's instructions. Reactions were terminated by placing reactions on ice until use in mitochondrial import assays. For mammalian targets, radiolabeled HADH (WT, S13A, S13E) precursor proteins were generated by in vitro transcription/translation reactions in rabbit reticulocyte lysate in the presence of 35 S-Methionine. Mitochondria were isolated from HEK293T cells as described before 92 . For import assays, mitochondria were resuspended in import buffer (250 mM sucrose, 5 mM magnesium acetate, 80 mM potassium acetate, 10 mM sodium succinate, 20 mM HEPES-KOH, pH 7.4) supplemented with 1 mM DTT and 5 mM ATP.
Where indicated, the membrane potential was dissipated prior to the import reaction by addition of 8 M antimycin A, 1 M valinomycin and 20 M oligomycin (AVO). Import reactions were started by addition of radiolabeled precursor proteins followed by incubation at 37°C for indicated times. Reactions were stopped by addition of AVO and non-imported precursor proteins removed by digestion with Proteinase K. Mitochondria were re-isolated by centrifugation at 10,000 x g for 10 min at 4°C and washed once in import buffer. Samples were analyzed on SDS-PAGE followed by digital autoradiography.
Images were quantified using ImageJ.
MPP processing assay
MPP processing assays using soluble mitochondrial extracts from mouse liver were performed as described previously 52 . In short, mitochondria were lysed in digitonin and the obtained extract incubated with radiolabeled precursor proteins. Samples were incubated for various time points at 37°C and reactions stopped by addition of 4x Laemmli buffer containing 2% (v/v) -mercaptoethanol. Samples were analyzed by SDS-PAGE and blotted onto PVDF membranes followed by autoradiography and immunodetection.
Generation of cell free protein synthesis reagents for phosphoserine incorporation
Cell free protein synthesis (CFPS) was used to generate phosphoserine incorporation as previously described 47 . The bacterial strain C321.ΔA.Δserb.Amp S was a gift from Jesse Rinehart (Addgene plasmid #68306) and was used to generate lysates for the CFPS reactions as described 47 . Bacteria were grown in 2xYPTG media (16g/L tryptone, 10g/L yeast extract, 5g/L NaCl, 5g/L K2HPO4, 3g/L KH2PO4, and 18g/L glucose filter-sterilized) with 2 mM phosphoserine and antibiotic selection at 30 ºC, 220 rpm. At OD 0.6, 1 mM IPTG was added and, at OD 3, cells were harvested by centrifugation (5,000 rcf, 15 min, 4 ºC). Bacteria were washed 3 times in cold S30 buffer (10 mM Tris-acetate pH 8.2, 14 mM magnesium acetate, 60 mM potassium acetate) with 1 mM DTT and the pellet was weighed, snap frozen, and stored at -80°C until lysis. Thawed bacteria were lysed by resuspension in S30 buffer with 2 mM DTT (0.8 mL per 1 g wet cells) and sonicated as described by Kwon and Jewett 93 (~900 J per 1 L cells). Lysates were supplemented with 1 mM DTT, clarified by centrifugation (12,000xg, 10 min, 4 ºC), and the clarified supernatant was incubated in a run-off reaction (1 hour, 250 rpm, 37 ºC, covered in foil).
The run-off reaction was clarified by a second centrifugation (12,000xg, 30 min, 4 ºC) and supernatant was collected with careful avoidance of loose cell debris. Lysates were aliquoted, snap frozen, and stored at -80°C until use.
Phosphoserine incorporation of recombinant proteins using cell free protein synthesis
CFPS reactions were performed as described by Oza et al 47 Some reagents can be pre-mixed, aliquoted, and stored at -20 ºC (*pre-mix, † amino acid mix prepared as described 94 ; ‡ salt mix at pH 7 with KOH) and the final reaction should be at pH 6.5-7. CFPS reactions were initiated by thoroughly mixing the cell extract, incubated for 17-20 hours at 30 ºC, and performed in 15, 30, or 50 uL reactions. For 50 uL S35 experiments, reactions were performed in a parafilmed, screwcap microcentrifuge tube with shaking (350 rpm).
PPTC7 and Ptc7p recombinant protein purification and phosphatase assays
N41-Ptc7p and catalytically inactive mutants were prepared as previously described 17 .
His8-MBP-tev-PPTC7 NΔ32 and mutants were expressed in E. coli (BL21[DE3]-RIPL strain) by autoinduction as previously described 17 . Cells were isolated and resuspended in lysis buffer (100 mM HEPES pH 7.2, 300 mM NaCl, 5 mM BME, 0.25 mM PMSF, 1 mg/mL lysozyme (Sigma), and 7.5% glycerol) Cells were lysed by sonication (4 °C), clarified by centrifugation (15, were allowed to proceed for 30 minutes at room temperature, after which they were terminated through the addition of sample buffer to 1x, boiled at 95C, and run on PhosTag gels to determine dephosphorylation efficiency.
Transfection and protein expression in 293 cells
293 cells were cultured in DMEM (high glucose, no pyruvate, Thermo-Fisher) supplemented with 10% heat inactivated fetal bovine serum (FBS) and 1x penicillin/streptomycin. Cells were grown in a temperature-controlled CO2 incubator at 37°C and 5% CO2. Cells were subcultured using 0.05% trypsin-EDTA every 2-3 days. For transfections, cells were split to ~40% confluence on Day 1. On Day 2, cells were transfected with 7.5 µg Maxiprep-purified plasmid supplemented with 20 µlg linear polyethylenimine (PEI, PolySciences), and 900 µL Opti-MEM (LifeTechnologies) as previously described 95 . After 48 hours, cells were collected or fixed for downstream applications.
Fluorescence Microscopy
Glass cover slips (#1.5) were sterilized and placed into single wells of 12 well plates. 293 cells were seeded at ~60% confluence and transfected with plasmids encoding GFP or N-terminal HADH-GFP fusions as previously described 95 
Quantification and Statistical Analysis
See each individual method for the associated statistical analysis. of overexpressed TIM50 WT, S104A, or S104E shows mutations do not destabilize proteins. C. Import assays in mitochondria isolated from GAL7-TIM50 yeast overexpressing wild type (WT) TIM50 or S104 mutants using the generic import cargo cytochrome b2-(167)∆19-DHFR. D.
Quantification of import rates from (C.) E. Import assays in mitochondria isolated from WT or can be dephosphorylated by recombinant PPTC7, but not a catalytically inactive mutant (D78A). D. Overexpression of WT, non-phosphorylatable (S13A) and phosphomimetic (S13E) HADH in 293 cells. S13E causes a shift in HADH processing relative to S13A and WT. E. A fusion protein of the first 28 amino acids of HADH and GFP was made, expressing WT or S13 mutants. S13E is sufficient to disrupt processing of the fusion protein. F. HADH and HADH S13E fusions overlap with MitoTracker Red staining, unlike EGFP with no targeting sequence. G. Import assays with recombinant 35S-labelled HADH, S13A, and S13E show that mutation of S13 alters HADH import efficiency into and processing in mitochondria isolated from HEK293T cells. Prec., precursor protein. H. MPP processing assay shows precursor HADH (p, top band) as well as cleavage into the mature form (m, bottom band) for both wild type and S13A HADH. Processing is completely disrupted in the S13E mutant, shown via the absence of the lowest band.* is a non-specific band in all three conditions. GRP75 and PMPCB blots demonstrate equal loading. 
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